A new preclinical study, conducted by Pudenz et al., demonstrates that combining chicory-derived inulin-type fructans with the human milk oligosaccharide (HMO) 2’-fucosyllactose (2’-FL) leads to additive, and even synergistic, effects on toddler gut microbiota. As one of the first studies to test combinations of prebiotics from chicory root with 2’-FL, it strengthens the argument for prebiotic blends to be used in milk formulas to support early-life gut health, with potential long-term benefits … [Read more...] about New preclinical study highlights unique combination of chicory-derived prebiotics and human milk oligosaccharide (HMO) for advancing toddler gut health
HMO
Boost for infant health: India approves dsm-firmenich’s 2′-FL HMO
dsm-firmenich, a global innovator in health, nutrition, and beauty, has announced the approval of its human milk oligosaccharide (HMO), 2'-O-Fucosyllactose (2'-FL)—commercially known as GLYCARE® 2FL—as a functional ingredient for early life nutrition in India. This regulatory milestone marks a new opportunity to enhance infant health, as well as support HMO innovation in the region, with GLYCARE® 2FL representing dsm-firmenich’s first HMO approval in India. The Food Safety and Standards … [Read more...] about Boost for infant health: India approves dsm-firmenich’s 2′-FL HMO
